This inventor holds 2 USPTO granted patents. Top assignee: Universitätsklinikum Regensburg. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Petra Rümmele: Innovator in Cancer Diagnosis and Treatment
Introduction
Petra Rümmele is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of cancer research through her innovative inventions. With a focus on the plasma membrane citrate transporter, her work aims to enhance the diagnosis and treatment of cancer.
Latest Patents
Petra Rümmele holds 2 patents related to her groundbreaking research. Her latest patents include a method for the diagnosis of cancer involving the plasma membrane citrate transporter (pmCiC). This invention also encompasses a modified substrate or modulator of pmCiC, the use of pmCiC as a tumor marker, and a method of screening for a modulator of pmCiC activity.
Career Highlights
Rümmele is affiliated with Universitätsklinikum Regensburg, where she continues to advance her research. Her work has garnered attention for its potential impact on cancer diagnostics and treatment methodologies.
Collaborations
Throughout her career, Petra has collaborated with esteemed colleagues, including Edward Geissler and Maria Mycielska. These partnerships have further enriched her research and innovation efforts.
Conclusion
Petra Rümmele's contributions to cancer research through her patents and collaborations highlight her role as a leading inventor in the field. Her work promises to pave the way for improved diagnostic and treatment options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile